title: [Helicobacter pylori: reasons for eradication].
abstract: Helicobacter pylori infection has been recognized as the most important pathogenetic principal of peptic ulcer disease, atrophic gastritis, gastric adenocarcinoma and MALT lymphoma. At the moment efforts are made to clarify it's role in functional dyspepsia, and gastro-esophageal reflux disease. The complex interactions between H. pylori infection and NSAIDs is another field of ongoing research. Diagnosis and eradication therapy are standardized. Established indications are peptic ulcer disease, low-grade gastric MALT lymphoma, early gastric cancer treated by mucosal resection and partial gastrectomy for gastric cancer. Atrophic gastritis, known to be a precancerous lesion, as well as first degree relatives of patients with gastric cancer is another widely accepted indication for eradication therapy. The recommended eradication regimens combine a proton pump inhibitor with clarithromycin and either amoxicillin or metronidazole--for a week.
authors.affiliation: Medizinische Klinik, Fachbereich Gastroenterologie, Städtische Kliniken Esslingen, Akademisches Lehrkrankenhaus der Universität Tübingen. mjschuster@web.de
authors.forename: M
authors.initials: M
authors.lastname: Schuster
mesh_terms: D000230:Adenocarcinoma / Q000517:prevention & control*; D000658:Amoxicillin / Q000008:administration & dosage; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000008:administration & dosage; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005756:Gastritis / Q000188:drug therapy*; D005757:Gastritis, Atrophic / Q000517:prevention & control; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000517:prevention & control*; D008795:Metronidazole / Q000008:administration & dosage; D010437:Peptic Ulcer / Q000517:prevention & control*; D054328:Proton Pump Inhibitors; D012307:Risk Factors; D055502:Secondary Prevention; D013274:Stomach Neoplasms / Q000517:prevention & control*
chemical_list: D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors; D008795:Metronidazole; D000658:Amoxicillin; D017291:Clarithromycin